REMS Integration Into Electronic Medical Records Mulled By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Public meeting in October will solicit comments on how to further reduce the burdens of the drug safety programs.
You may also be interested in...
FDA Simplifies The Process For REMS Changes
Some typographical changes can be submitted and noted later, according to new draft guidance. Major changes still require pre-approval.
REMS And Generics: GPhA Needs Legislation, Continues Education
GPhA says congressional action is only remedy after study estimates $5.4 billion in potential savings is lost annually because of brand manufacturers using REMS to prevent generic competition.
FDAAA Fading? REMS Use Continues To Decline As Drug Safety Law Matures
FDA’s use of REMS continues to fall to almost undetectable levels, with the agency using the safety tools just a handful of times in the sixth full year of the program. REMS are now very much the exception and not the rule for new products – but still a very important exception.